FIELD: medicine; pharmaceuticals.
SUBSTANCE: present invention relates to crystalline salts of 1-(4-(2-((1-(3,4-difluorophenyl)-1H-pyrazol-3-yl)methoxy)ethyl)piperazin-1-yl)ethanone, specifically to hydrochloride, maleate, fumarate, malonate, succinate, oxalate and hydrobromide. Invention also relates to a pharmaceutical composition containing said salts, and to use thereof in therapy and/or prevention of sigma-receptor related diseases.
EFFECT: novel crystalline salts which can be used in medicine are obtained and described.
10 cl, 25 dwg, 12 tbl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
PYRAZOLE COMPOUNDS AS SIGMA RECEPTOR INHIBITORS | 2011 |
|
RU2582338C2 |
NEW CRYSTALLINE FORM OF 2-{3-[2-(1-{[3,5-BIS(DIFLUOROMETHYL)-1H-PYRAZOL-1-YL]ACETYL}PIPERIDIN-4-YL)-1,3-THIAZOL-4-YL]-4,5-DIHYDRO-1,2-OXAZOL-5-YL}-3-CHLOROPHENYLMETHANE SULPHONATE | 2014 |
|
RU2691948C2 |
SIGMA-RECEPTOR INHIBITORS | 2005 |
|
RU2417987C2 |
AZOLE DERIVATIVE | 2012 |
|
RU2573634C2 |
SPHINGOSINE-1-PHOSPHATE BINDING INHIBITOR | 2007 |
|
RU2395499C2 |
PYRAZOL-4-YL-HETEROCYCLYL-CARBOXAMIDE COMPOUNDS AND METHODS FOR APPLICATION | 2012 |
|
RU2638552C2 |
CRYSTALLINE FORM (S)-N-(5-((R)-2-(2,5-DIFLUOROPHENYL)-PYRROLIDIN-1-YL)-PYRAZOLO[1,5-A]PYRIMIDIN-3-YL)-3-HYDROXYPYRROLIDINE-1-CARBOXAMIDE HYDROSULPHATE | 2015 |
|
RU2723990C2 |
SALTS OF 4-[2-[[5-METHYL-1-(2-NAPHTHALINYL)-1H-PYRAZOL-3-YL]OXY]ETHYL]MORPHOLINE | 2010 |
|
RU2559325C2 |
METHOD FOR PREPARING VORICONAZOLE AND ITS ANALOGUES | 2013 |
|
RU2619928C2 |
ANTIBACTERIAL COMPOUND NITRATE SALTS | 2001 |
|
RU2288231C2 |
Authors
Dates
2020-07-28—Published
2016-09-01—Filed